| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |